- Home
- BITF vs CDNA Comparison
BITF vs CDNA Comparison
Compare BITF & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BITF
- CDNA
- Stock Information
- Founded
- BITF 2017
- CDNA 1998
- Country
- BITF Canada
- CDNA United States
- Employees
- BITF N/A
- CDNA N/A
- Industry
- BITF Finance: Consumer Services
- CDNA Medical Specialities
- Sector
- BITF Finance
- CDNA Health Care
- Exchange
- BITF Nasdaq
- CDNA Nasdaq
- Market Cap
- BITF 1.0B
- CDNA 1.1B
- IPO Year
- BITF N/A
- CDNA 2014
- Fundamental
- Price
- BITF $1.09
- CDNA $17.64
- Analyst Decision
- BITF Strong Buy
- CDNA Buy
- Analyst Count
- BITF 7
- CDNA 8
- Target Price
- BITF $4.43
- CDNA $29.43
- AVG Volume (30 Days)
- BITF 32.3M
- CDNA 879.7K
- Earning Date
- BITF 03-25-2025
- CDNA 05-08-2025
- Dividend Yield
- BITF N/A
- CDNA N/A
- EPS Growth
- BITF N/A
- CDNA N/A
- EPS
- BITF N/A
- CDNA 0.93
- Revenue
- BITF $182,959,000.00
- CDNA $333,785,000.00
- Revenue This Year
- BITF $35.59
- CDNA $13.32
- Revenue Next Year
- BITF $100.05
- CDNA $14.99
- P/E Ratio
- BITF N/A
- CDNA $18.96
- Revenue Growth
- BITF 43.88
- CDNA 19.07
- 52 Week Low
- BITF $1.06
- CDNA $7.42
- 52 Week High
- BITF $3.28
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- BITF 38.20
- CDNA 32.15
- Support Level
- BITF $1.06
- CDNA $17.73
- Resistance Level
- BITF $1.26
- CDNA $19.03
- Average True Range (ATR)
- BITF 0.11
- CDNA 1.28
- MACD
- BITF 0.01
- CDNA -0.36
- Stochastic Oscillator
- BITF 11.54
- CDNA 2.03
About BITF Bitfarms Ltd.
Bitfarms Ltd engaged in the cryptocurrency Mining industry mainly consists of selling its computational power used for hashing calculations for cryptocurrency mining in multiple jurisdictions. Its geographic operations are currently located in Canada, the United States, Argentina, and Paraguay. It owns and operates server farms comprised of computers designed to validate transactions on the Bitcoin Blockchain.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.